PDL BioPharma Inc (NASDAQ:PDLI)

7.00
Delayed Data
As of 3:54pm ET
 +0.05 / +0.72%
Today’s Change
6.52
Today|||52-Week Range
10.26
-9.21%
Year-to-Date

Today’s Trading

Previous close6.95
Today’s open6.96
Day’s range6.90 - 7.01
Volume4,453,601
Average volume (3 months)2,904,547
Market cap$1.1B
Dividend yield8.57%
Data as of 3:54pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+14.48%
Earnings growth (this year)+28.61%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+18.26%
P/E ratio3.6
Price/Sales2.66
Price/Book8.57

Competitors

 Today’s
change
Today’s
% change
ARRYArray Biopharma Inc-0.14-1.79%
EBSEmergent BioSolution...-0.34-1.12%
MACKMerrimack Pharmaceut...-0.12-1.07%
ARNAArena Pharmaceutical...-0.26-5.47%
Data as of 3:54pm ET, 02/27/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$0.50
Annual revenue (last year)$442.9M
Annual profit (last year)$264.5M
Net profit margin59.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account